HSG catheters, also sometimes called HS, SIS or SGH catheters, are used for hysterosalpingography and sonohysterography. Technically, HSG catheters are used for hysterosalpingography procedures while HS, SIS and SGH catheters are simpler and are utilized during a sonohysterography procedure. However, these catheters are used interchangeably and can be used for both procedures. For the purpose of this report, as these catheters are used interchangeably, they will both be considered under the HSG catheter market. Despite the slight decline in market value, unit sales are increasing, thus the reduction in market value is due to ASP depreciation.
Unit sales are expected to increase during the forecast period due to increases in procedure rates. As HSG catheters are often used to test female fertility, the projected increases in unit sales correspond to the increases in fertility treatments. Fertility treatments are becoming more common as the average age of pregnancy has increased substantially. As women continue to delay pregnancy, the need for fertility treatments is projected to increase.
Abstract Hysterosalpingography (HSG) catheters, also known as HS catheters, are used for hysterosalpingography and sonohysterography procedures. These devices are used by practitioners to inject either a contrast media or sterile saline into the uterine cavity and fallopian tubes through the cervical opening. These procedures are used to evaluate infertility, pregnancy loss, uterine bleeding or menstrual disorders, and to asses tubal patency and uterine pathology.
Hysterosalpingography (HSG) requires the infusion of radiographic contrast dye via the HSG catheter. This radiologic procedure uses X-rays to determine if there are blockages in the fallopian tubes and where they may be located as the dye travels through the reproductive tract. Sonohysterography, on the other hand, uses sterile saline to help render images of the uterus and any abnormalities with the aid of a transabdominal ultrasound.
Our reports have been used by over 10K customers, including:
539 pages •
By Roots Analysis Private Ltd.
• Jun 2021
Around 90% of the drug candidates in the current development pipeline and close to 40% of marketed pharmacological products, have been associated with concerns related to solubility and / or permeability. , In this context, considering modern regulatory standards, a large number of potential therapeutic leads...
‘Elastomeric Pumps- Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of elastomeric pumps and the historical and forecasted elastomeric pumps market trends in the US, EU5 (Germany, France, Spain, Italy, and United Kingdom) and Japan.
The elastomeric pumps market report provides...
256 pages •
By Roots Analysis Private Ltd.
• Feb 2021
INTRODUCTION Over time, advances in molecular biology and pharmacological chemistry have enabled the identification of biological targets localized in the subcellular space, and development of therapeutic leads against them. In fact, there are several clinical conditions, which were previously considered undruggable since...
The major factors for the growth of the novel drug delivery systems (NDDS) market include the growing need of controlled release of drugs, advancement in pharmacology promoting increased adoption of novel drug delivery systems (NDDS), and technological advancements promoting the development of NDDS. There has been a remarkable increase...
Report Scope: The scope of the report includes an overview of the global market for nanoparticles in biotechnology, drug development and drug delivery, and analyses of global market trends, using 2019 as the base year and forecasting 2020 through 2025 with compound annual growth rate (CAGR) projections. The report...
The Europe liposome drug delivery market was valued at US$ 1,164.54 million in 2019 and is projected to reach US$ 2,160.12 million by 2027; it is expected to grow at a CAGR of 8.2% during the forecast period. The growing R&D expenditure on drug delivery, growing demand for non-invasive drug delivery devices. and the development of new...
The Europe wearable injectors market is expected to reach US$ 3586.82 million in 2027 from US$ 1539.88 million in 2019. The market is estimated to grow with a CAGR of 11.3 % from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...
INTRODUCTION Over the years, advances in cell biology and pharmacology have led to the development of a variety of advanced biologics, which experts believe, possess the potential to address several unmet needs associated with the treatment of different types of diseases. Currently, there are more than 1,000 cell and gene...
Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments in the medical and dental fields.The company’s medical specialties include anesthesiology, pain medicine, orthopedic surgery, physical medicine and...
Medical Devices Sales
Health Provider Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.